Showing results (51-60 of 186) with videos related to

Sort By:
Pageof 19
Journal of Managed Care & Specialty Pharmacy|April 26, 2022
International reference pricing of pharmaceuticals in the United States: Implications for potentially curative treatmentsSean D Sullivan, Kiera D Sullivan, Omar Dabbous, et al.
Clinical Therapeutics|March 13, 2013
Comparative-effectiveness research to aid population decision making by relating clinical outcomes and quality-adjusted life yearsJonathan D Campbell, Judy Zerzan, Louis P Garrison, et al.
Health Affairs (Project Hope)|October 6, 2010
A flexible approach to evidentiary standards for comparative effectiveness researchLouis P Garrison, Peter J Neumann, Paul Radensky, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|July 7, 2019
How Does Option Value Affect the Potential Cost-Effectiveness of a Treatment? The Case of Ipilimumab for Metastatic MelanomaMeng Li, Anirban Basu, Caroline Bennette, et al.
Journal of Medical Economics|May 14, 2019
Determinants of specialist physician ambulatory visits: a neurology exampleDavid N van der Goes, John P Ney, Louis P Garrison
Journal of Pain & Palliative Care Pharmacotherapy|December 21, 2017
Prevalence of and Comorbid Health Conditions Associated With Pediatric Prescription Opioid Use in the USSouvik Banerjee, Carl L Roland, Richard Willke, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 26, 2018
An Overview of Value, Perspective, and Decision Context-A Health Economics Approach: An ISPOR Special Task Force Report [2]Louis P Garrison, Mark V Pauly, Richard J Willke, et al.
American Journal of Medical Genetics. Part C, Seminars in Medical Genetics|March 1, 2023
A review of economic issues for gene-targeted therapies: Value, affordability, and accessLouis P Garrison, Andrew W Lo, Richard S Finkel, et al.
BMC Medicine|January 29, 2024
Is the price right? Paying for value today to get more value tomorrowSreeram V Ramagopalan, Jose Diaz, Grace Mitchell, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|July 24, 2008
The potential clinical and economic outcomes of pharmacogenomic approaches to EGFR-tyrosine kinase inhibitor therapy in non-small-cell lung cancerJosh J Carlson, Louis P Garrison, Scott D Ramsey, et al.
Pageof 19